We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA approved Idvynso (doravirine/islatravir) — the first two-drug regimen without INSTI and tenofovir. Learn why this is a new standard of therapy for aging HIV patients. Read details.
